Elizabeth Thiele, MD, PhD sat down with Neurology Advisor to discuss the state of cannabidiol research

Cannabidiol And Epilepsy

Elizabeth Thiele, MD, PhD, Director of the Pediatric Epilepsy Center at Massachusetts General Hospital, Director of the Carol and James Herscot Center for Tuberous Sclerosis Complex, and Professor of neurology at Harvard Medical School. Elizabeth Thiele, MD, PhD csat down with Neurology Advisor to discuss the state of cannabidiol research for the treatment of refractory epilepsies.

 

Transcript From YouTube:

I’m Elizabeth Theil Md PhD director the hospital, i’m also directing the first neurosis complex at the Mass General Hospital in Boston and a professor of neurology at Harvard Medical School. I’ve been a child pediatric at a couple of colleges now for 20 years and it’s been very exciting over the past 10 to 15 years to see the number of new anticonvulsant medications that have become available so the number of treatment options we have for children, Its many more than when I started. The frustration for all of us, the families living with children living with epilepsy and people taking care of them is there even with those new medications. We still have a large portion of children who’s seizures are not controlled and remain refractory. So there continues to be a big unmet need for effective treatments in epilepsy and over the past several years there’s been increasing anecdotal reports on medical marijuana. It became available in first California and later Colorado that marijuana extracts, medical marijuana, can be effective in treating epilepsy in many children. Several years ago an account of GW Pharma was identified as company from the CONT…

Comments